Phase 2 Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose pain level falls between 40 and 95 on a standard pain rating scale (called a Visual Analog Scale) at the time of initial screening.
- People who have experienced daily pain for at least 12 weeks, based on their own report or their medical records.
- People who score 30 or below on a questionnaire that measures pain-related negative thinking (called the Pain Catastrophizing Scale).
- People with a body mass index (a measure of body weight relative to height) below 40.
- People who are willing to keep their current non-medication pain treatments (such as physical therapy) unchanged and not start any new ones during the study.
- People who are willing to stop all medications taken for chronic pain during the study, except for one allowed rescue medication.
Who may not be able to join:
- People with certain serious heart rhythm problems, including second- or third-degree heart block, AV dissociation, or a history of a dangerous rapid heartbeat (ventricular tachycardia).
- People who have had a procedure in the past 6 months designed to permanently reduce feeling in the area where their pain is located (such as nerve ablation).
- People who have any surgery planned during the study period, for any reason.
- People who have an acute, serious, or unstable health condition, or any other medical illness that the study doctor believes would make participation unsafe.
- People who have had cancer within the past 2 years, with the exception of certain common skin cancers (basal cell or squamous cell carcinoma) that were fully removed by surgery.
- People who have fibromyalgia.
- People who have a substance use disorder as defined by the current standard medical guidelines (DSM-5).
- People who have any significant abnormal findings at screening in their physical exam, neurological exam, vital signs, heart tracing (ECG), or blood/lab tests that the study doctor considers concerning.
- People who test positive for HIV at screening.
- People who have a history of alcohol, illegal drug, painkiller, or narcotic use disorder within the 2 years before screening.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 1-317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants Who Were Allocated to Each ISA
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.